FierceBiotech names Brii Biosciences as one of its “Fierce 15” Biotech Companies of 2018
Oct 02, 2018
Back
Beijing, China – October 2, 2018 – Brii Biosciences today was named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.
Beijing, China – October 2, 2018 – Brii Biosciences today was named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.
Brii Biosciences was created in 2018 to bring world-class medicines and diagnostics, healthcare technologies, and novel commercialization models to accelerate medical innovation in China. Brii Bio is working on all of these fronts to create a new paradigm devoted to improving patients’ well-being, serving the public interest and offering strong returns for our business partners.
“We believe that there is tremendous opportunity to dramatically change the way healthcare is delivered and consumed in China,” said Zhi Hong, Ph.D., Brii Bio CEO. “Innovations in medicine, technology and public policy are creating new opportunities to improve health for patients across China at an unparalleled scale. We are delighted and honored to join the Fierce 15, as we chart our new and exciting course.”
The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition. This is FierceBiotech’s 16th annual Fierce 15 selection.
An internationally recognized daily report reaching a network of over 285,000 biotech and pharma industry professionals, FierceBiotech provides subscribers with an authoritative analysis of the day’s top stories. Every year FierceBiotech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.
About FierceBiotech
FierceBiotech is the biotech industry’s daily monitor, an email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 150,000 top biotech professionals rely on FierceBiotech for an insider briefing on the day’s top stories. Signup is free at www.fiercebiotech.com/signup.
About Brii Biosciences
Brii Biosciences was created to bring world-class medicines and diagnostics, healthcare technologies, and novel commercialization models to accelerate medical innovation in China. Our strategy aims to bring together partners to create a fully enabled and integrated platform addressing the unique innovation and access challenges in the most populous country in the world. Intensely focused and driven by an ambition that matches the challenge ahead, our organization is united by a singular vision: to become the best healthcare company in China valued by our patients, society, partners and employees.
CONTACTS:
Rebecca Willumson
FierceBiotech
202-824-5050
Lindy Devereux
646-515-5730
Previous
